Clinical Trial Update: Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

View source ↗

Summary

The trial evaluating approaches to treating Hemophilia A and Hemophilia B in Spain has completed, with Wyeth now a wholly owned subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia A, Hemophilia B | Status: COMPLETED